OPGN

OpGen (OPGN)

About OpGen (OPGN)

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. It engages in the development of molecular information products and services for global healthcare settings. The firm's also offers guidance to clinicians about life threatening infections, improving patient outcomes, and decreasing the spread of infections caused by multidrug-resistant microorganisms. Its products include Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction. The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.

Details

Daily high
$0.72
Daily low
$0.69
Price at open
$0.70
52 Week High
$9.90
52 Week Low
$0.66
Market cap
7.3M
Dividend yield
0.00%
Volume
12,402
Avg. volume
6,743
P/E ratio
-.06

OpGen News

Details

Daily high
$0.72
Daily low
$0.69
Price at open
$0.70
52 Week High
$9.90
52 Week Low
$0.66
Market cap
7.3M
Dividend yield
0.00%
Volume
12,402
Avg. volume
6,743
P/E ratio
-.06